Bcl-2

From WikiMD's Medical Encyclopedia

Revision as of 22:30, 15 December 2024 by Prab (talk | contribs) (CSV import)

Bcl-2

The Bcl-2 (B-cell lymphoma 2) protein is a key regulator of apoptosis, the process of programmed cell death, which is crucial for maintaining cellular homeostasis and development. Bcl-2 is part of a larger family of proteins known as the Bcl-2 family, which includes both pro-apoptotic and anti-apoptotic members. The balance between these opposing forces determines the fate of the cell.

Structure

Bcl-2 is a membrane protein that is primarily located on the outer membrane of mitochondria, but it can also be found on the endoplasmic reticulum and nuclear envelope. The protein is characterized by the presence of Bcl-2 homology (BH) domains, which are critical for its function. These domains allow Bcl-2 to interact with other proteins in the Bcl-2 family, forming heterodimers that can either promote or inhibit apoptosis.

Function

Bcl-2 functions as an anti-apoptotic protein, meaning it prevents the initiation of apoptosis. It does so by binding to and sequestering pro-apoptotic proteins such as Bax and Bak, preventing them from permeabilizing the mitochondrial outer membrane. This action inhibits the release of cytochrome c and other pro-apoptotic factors from the mitochondria, thereby blocking the activation of the caspase cascade that leads to cell death.

Role in Cancer

The overexpression of Bcl-2 is associated with several types of cancer, including B-cell lymphoma, from which it derives its name. In cancer cells, high levels of Bcl-2 can prevent apoptosis, allowing the cells to survive longer than they should, contributing to tumor growth and resistance to chemotherapy. Targeting Bcl-2 with specific inhibitors, such as venetoclax, has become a therapeutic strategy in treating certain cancers.

Research and Therapeutic Implications

Research into Bcl-2 and its family members continues to be a significant area of interest, particularly in understanding the mechanisms of apoptosis and developing new cancer therapies. Bcl-2 inhibitors are being tested in clinical trials for their efficacy in treating various malignancies.

Also see





Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99 with insurance

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.